180 related articles for article (PubMed ID: 35654683)
1. Combined 0.01% atropine with orthokeratology in childhood myopia control (AOK) study: A 2-year randomized clinical trial.
Tan Q; Ng AL; Cheng GP; Woo VC; Cho P
Cont Lens Anterior Eye; 2023 Feb; 46(1):101723. PubMed ID: 35654683
[TBL] [Abstract][Full Text] [Related]
2. Higher order aberrations and axial elongation in combined 0.01% atropine with orthokeratology for myopia control.
Vincent SJ; Tan Q; Ng ALK; Cheng GPM; Woo VCP; Cho P
Ophthalmic Physiol Opt; 2020 Nov; 40(6):728-737. PubMed ID: 32888318
[TBL] [Abstract][Full Text] [Related]
3. One-year results of 0.01% atropine with orthokeratology (AOK) study: a randomised clinical trial.
Tan Q; Ng AL; Choy BN; Cheng GP; Woo VC; Cho P
Ophthalmic Physiol Opt; 2020 Sep; 40(5):557-566. PubMed ID: 32776533
[TBL] [Abstract][Full Text] [Related]
4. Combined Atropine with Orthokeratology for Myopia Control: Study Design and Preliminary Results.
Tan Q; Ng AL; Cheng GP; Woo VC; Cho P
Curr Eye Res; 2019 Jun; 44(6):671-678. PubMed ID: 30632410
[No Abstract] [Full Text] [Related]
5. Repeatability of pupil size measurements with NIDEK OPD-Scan III in myopic children.
Tan Q; Ng AL; Cheng GP; Woo VC; Cho P
Ophthalmic Physiol Opt; 2021 Mar; 41(2):431-436. PubMed ID: 33294971
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of 0.01% atropine alone or combined with orthokeratology for children with myopia: A meta-analysis.
Wang Z; Wang P; Jiang B; Meng Y; Qie S; Yan Z
PLoS One; 2023; 18(7):e0282286. PubMed ID: 37494360
[TBL] [Abstract][Full Text] [Related]
7. Additive effects of orthokeratology and atropine 0.01% ophthalmic solution in slowing axial elongation in children with myopia: first year results.
Kinoshita N; Konno Y; Hamada N; Kanda Y; Shimmura-Tomita M; Kakehashi A
Jpn J Ophthalmol; 2018 Sep; 62(5):544-553. PubMed ID: 29974278
[TBL] [Abstract][Full Text] [Related]
8. Combination of orthokeratology lens with 0.01% atropine in slowing axial elongation in children with myopia: a randomized double-blinded clinical trial.
Yu S; Du L; Ji N; Li B; Pang X; Li X; Ma N; Huang C; Fu A
BMC Ophthalmol; 2022 Nov; 22(1):438. PubMed ID: 36380280
[TBL] [Abstract][Full Text] [Related]
9. Impact of pupil diameter on axial growth in orthokeratology.
Chen Z; Niu L; Xue F; Qu X; Zhou Z; Zhou X; Chu R
Optom Vis Sci; 2012 Nov; 89(11):1636-40. PubMed ID: 23026791
[TBL] [Abstract][Full Text] [Related]
10. The Efficacy of Atropine Combined With Orthokeratology in Slowing Axial Elongation of Myopia Children: A Meta-Analysis.
Gao C; Wan S; Zhang Y; Han J
Eye Contact Lens; 2021 Feb; 47(2):98-103. PubMed ID: 33060414
[TBL] [Abstract][Full Text] [Related]
11. Retinal image quality in myopic children undergoing orthokeratology alone or combined with 0.01% atropine.
Tan Q; Cho P; Ng ALK; Cheng GPM; Woo VCP; Vincent SJ
Eye Vis (Lond); 2023 Jun; 10(1):21. PubMed ID: 37259133
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of combined orthokeratology and 0.01% atropine for myopia control: the study protocol for a randomized, controlled, double-blind, and multicenter trial.
Yuan Y; Zhu C; Liu M; Zhou Y; Yang X; Zheng B; Li Z; Mao X; Ke B
Trials; 2021 Dec; 22(1):863. PubMed ID: 34852833
[TBL] [Abstract][Full Text] [Related]
13. Low concentration atropine combined with orthokeratology in the treatment of axial elongation in children with myopia: A meta-analysis.
Yang N; Bai J; Liu L
Eur J Ophthalmol; 2022 Jan; 32(1):221-228. PubMed ID: 33678055
[TBL] [Abstract][Full Text] [Related]
14. The effects of entrance pupil centration and coma aberrations on myopic progression following orthokeratology.
Santodomingo-Rubido J; Villa-Collar C; Gilmartin B; Gutiérrez-Ortega R; Suzaki A
Clin Exp Optom; 2015 Nov; 98(6):534-40. PubMed ID: 26283026
[TBL] [Abstract][Full Text] [Related]
15. Changes in subfoveal choroidal thickness in myopic children with 0.01% atropine, orthokeratology, or their combination.
Hao Q; Zhao Q
Int Ophthalmol; 2021 Sep; 41(9):2963-2971. PubMed ID: 33954859
[TBL] [Abstract][Full Text] [Related]
16. Long-term Efficacy of Orthokeratology Contact Lens Wear in Controlling the Progression of Childhood Myopia.
Santodomingo-Rubido J; Villa-Collar C; Gilmartin B; Gutiérrez-Ortega R; Sugimoto K
Curr Eye Res; 2017 May; 42(5):713-720. PubMed ID: 27767354
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Administration of 0.02% Atropine and Orthokeratology for Myopia Control.
Lyu Y; Ji N; Fu AC; Wang WQ; Wei L; Qin J; Zhao BX
Eye Contact Lens; 2021 Feb; 47(2):81-85. PubMed ID: 32443010
[TBL] [Abstract][Full Text] [Related]
18. Efficacy, Safety and Acceptability of Orthokeratology on Slowing Axial Elongation in Myopic Children by Meta-Analysis.
Li SM; Kang MT; Wu SS; Liu LR; Li H; Chen Z; Wang N
Curr Eye Res; 2016 May; 41(5):600-8. PubMed ID: 26237276
[TBL] [Abstract][Full Text] [Related]
19. Overnight orthokeratology is comparable with atropine in controlling myopia.
Lin HJ; Wan L; Tsai FJ; Tsai YY; Chen LA; Tsai AL; Huang YC
BMC Ophthalmol; 2014 Mar; 14():40. PubMed ID: 24685184
[TBL] [Abstract][Full Text] [Related]
20. The effect of 0.01% atropine and orthokeratology on ocular axial elongation for myopia children: A meta-analysis (a PRISMA-compliant article).
Yu Y; Liu J
Medicine (Baltimore); 2022 May; 101(18):e29191. PubMed ID: 35550467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
